Qisi Wu
Beibei Gong2
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
- 1Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
- 2Department of Radiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
A corrigendum on
Case report and literature analysis: Autoimmune cerebellar ataxia associated with homer-3 antibodies
by Wu, Q., Gong, B., Jiang, A., and Qin, X. (2022). Front. Neurol. 13:951659. doi: 10.3389/fneur.2022.951659
In the published article, there was an error in the Funding statement. The grant number was incorrect. The correct Funding statement appears below.
Funding
This work was supported by the Natural Science Foundation of Chongqing (grant no. cstc2020jcyj-msxmX0765).
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: autoimmune cerebellar ataxia, Homer-3 antibody, brain MRI enhanced abnormalities, relapse, rituximab
Citation: Wu Q, Gong B, Jiang A and Qin X (2023) Corrigendum: Case report and literature analysis: Autoimmune cerebellar ataxia associated with homer-3 antibodies. Front. Neurol. 14:1187907. doi: 10.3389/fneur.2023.1187907
Received: 16 March 2023; Accepted: 17 March 2023;
Published: 28 March 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Wu, Gong, Jiang and Qin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Xinyue Qin, cWlueGlueXVlY3EyMDA4QHNpbmEuY29t